News & Trends - Pharmaceuticals
NSW government fails to back mental health inquiry findings with essential funding
NSW Government has support for 24 of 39 recommendations from the Portfolio Committee’s Inquiry Report on ‘Equity, accessibility and appropriate […]
MoreNews & Trends - Pharmaceuticals
More Aussies cut back on GP visits, medicines and diagnostics due to financial strain
Pharma News: New research highlights the growing impact of cost-of-living pressures on Australians’ healthcare decisions, revealing troubling trends in delayed […]
MoreNews & Trends - Pharmaceuticals
Will real-world evidence be the key to securing PBS listing for J&J’s depression therapy?
Pharma News: Depression, a complex and often life-altering condition, stands as the leading cause of disability worldwide, impacting an estimated […]
MoreNews & Trends - Pharmaceuticals
Health leaders call for ban on Mundipharma amid growing ethical concerns
Pharma News: The Thoracic Society of Australia and New Zealand (TSANZ) and the Public Health Association of Australia (PHAA) have […]
MoreNews & Trends - Pharmaceuticals
Clinicians and patients welcome first PBS-listing for rare, advanced kidney cancer
Pharma News: Ipsen’s tyrosine kinase inhibitor (TKI) is now available on the Pharmaceutical Benefits Scheme (PBS) for patients with advanced […]
MoreNews & Trends - Pharmaceuticals
Caution issued over patient safety as 60-day prescription expands to asthma medicines
Pharma News: From September 1, coinciding with the start of National Asthma Week, Australians will have access to over 70 […]
MoreNews & Trends - Pharmaceuticals
New funding to expand stroke registry as audit data reveals concerning findings
Pharma News: A 3-year, $1.5 million funding boost from the government’s National Clinical Quality Registry Program will enable the Australian […]
MoreNews & Trends - Pharmaceuticals
Department of Health review reveals mixed results on minimum stockholding policy
Pharma News: The Department of Health has concluded a 12-month review of the Minimum Stockholding Requirements (MSR) policy, assessing its […]
MoreNews & Trends - Pharmaceuticals
AstraZeneca-Daiichi Sankyo targeted therapy listed on the PBS in advanced breast cancer
Pharma News: Breast cancer, the second most diagnosed cancer in Australia and the leading cancer among women, affects around 58 […]
MoreNews & Trends - Pharmaceuticals
Leadership homecoming at Organon ANZ: New country head returns to steer future growth
Pharma News: Organon has announced the appointment of Bilal Somra as the new Country Lead for Australia and New Zealand […]
MoreRecent Posts in Pharma, MedTech & Biotech
NACCHO-Pfizer partnership ignites global journey for First Nations pharmacy leaders
September 6, 2024
in Medical and Science
First report exposes glaring gaps in healthcare sector sustainability
September 6, 2024
in ESG
Expanded access to Shingrix is a start: ‘We need reform for all current and future vaccines’
September 6, 2024
in News & Trends - Pharmaceuticals
NSW government fails to back mental health inquiry findings with essential funding
September 6, 2024
in News & Trends - Pharmaceuticals
More Aussies cut back on GP visits, medicines and diagnostics due to financial strain
September 5, 2024
in News & Trends - Pharmaceuticals
Health Minister rules out taxpayer bailout for private hospitals amidst financial crisis
September 5, 2024
in News & Trends - MedTech & Diagnostics
Digital care model improves diabetes life expectancy, paving way for new partnership in clinical trials
September 5, 2024
in Medical and Science
Victorian health crisis: Nearly half a billion dollar emergency funding to cover hospital staff salaries
September 5, 2024
in News & Trends - MedTech & Diagnostics
Follow Us
Partner with us
Medical and Science
NACCHO-Pfizer partnership ignites global journey for First Nations pharmacy leaders
Medical & Science: NACCHO has announced the recipients of the 2024 Aboriginal and Torres Strait Islander Pharmacy Leadership Grant: Jes […]
MoreNews & Trends - Pharmaceuticals
Expanded access to Shingrix is a start: ‘We need reform for all current and future vaccines’
Pharma News: Access to GSK’s Shingrix vaccine, following the 2023-24 federal budget decision, has been limited to “immunocompromised patients aged […]
MoreNews & Trends - Pharmaceuticals
NSW government fails to back mental health inquiry findings with essential funding
NSW Government has support for 24 of 39 recommendations from the Portfolio Committee’s Inquiry Report on ‘Equity, accessibility and appropriate […]
More